Abstract
The Contegra valve-containing conduit (Medtronic) has been used for reconstruction of right ventricle outflow pathway in congenital heart disease surgery since 1999. The literature on immune inflammation of a xenovein is scarce and controversial. We present a clinical case of a pronounced cellular immune response to the Contegra device.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
